More specifically, co-immunized mice by tumor antigen and FIP-fve showed induction of antigen-specific antibodies and increased the expansion of antigen-specific IFN-γ-producing CD4+ T cells and CD8+ T cells, leading to an enhanced antigen-specific humoral and cellular type 1 anti-tumor immune response (90). The gene discussed is CD8A; the disease is neoplasm.